Summary
The metabolic fate of small doses of a newly prepared, highly radioactive angiotensin II has been studied in anaesthetized rats. Doses of 25 or 100 ng were administered in a single injection and the following parameters were studied: 1. The variation with time of the concentration of total radioactivity in plasma and urine. 2. The nature of this radioactivity, classifying it as protein-bound, free immunoreactive (angiotensin, 2–8 heptapeptide or 3–8 hexapeptide) or free nonimmunoreactive (smaller tyrosine-containing fragments). 3. The distribution of radioactivity in various tissues, including a detailed study of different regions of the brain.
The main results are that: 1. angiotensin II and/or metabolites are rapidly removed from the circulation, mainly by tissue uptake and to a lesser extent by urinary excretion (which reached 12% of the dose injected after 1 hour); 2. remaining angiotensin II circulating in the blood is rapidly degraded, presumably by tissue peptidases; 3. radioactivity concentrates in the adrenal glands, kidney, liver and pituitary and does not readily pass the blood-brain barrier; 4. there is a possible binding of angiotensin and metabolites on to plasma proteins.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Angles d'Auriac, G., Meyer, P., Milliez, P.: Reaction croisée des anticorps antiangiotensine II avec d'autres analogues de l'angiotensine. C. R. Acad. Sci. (Paris)268, 1886–1888 (1969).
Bakhle, Y. S., Reynard, A. M., Vane, J. R.: Metabolism of the angiotensins in isolated perfused tissues. Nature (Lond.)222, 956–959 (1969).
Baudouin, M., Meyer, P., Worcel, M.: Specific binding of3H-angiotensin II in rabbit aorta. Biochem. biophys. Res. Commun.42, 434–440 (1971).
Biron, P., Meyer, P., Panisset, J. C.: Removal of angiotensins from the systemic circulation. Canad. J. Physiol. Pharmacol.46, 175–178 (1968).
Bonjour, J. P., Melvin, R. H.: Stimulation of ADH release by the renin-angiotensin system. Amer. J. Physiol.218, 1555–1559 (1970).
Boyd, G. E., Landon, J., Peart, W. S.: Radioimmunoassay for determining plasma levels of angiotensin II. Lancet1967 II, 1002–1005.
Bumpus, F. M.: Circulat. Res.9, 767 (1961).
—, Smeby, R. R., Page, I. H., Khairallah, P. A.: Distribution and metabolic fate of angiotensin II and various derivatives. Canad. med. Ass. J.90, 190–193 (1964).
Cain, M. D., Catt, K. J., Coghlan, J. P., Blair-West, J. R.: Evaluation of angiotensin II metabolism in sheep by radioimmunoassay. Endocrinology86, 955–964 (1970).
Doyle, A. E., Louis, W. J., Jerums, G., Osborn, E. C.: Metabolism and blood levels following infusion of a radioactive analog of angiotensin. Amer. J. Physiol.215, 164–168 (1968).
Epstein, A. N., Fitzsimons, J. T., Simons, B. J.: Drinking induced by injection of angiotensin into the brain of the rat. J. Physiol. (Lond.)210, 457–474 (1970).
Fitzsimons, J. T., Simons, B. J.: The effect on drinking in the rat of an intravenous infusion of angiotensin, given alone or in combination with other stimuli for thirst. J. Physiol. (Lond.)203, 45–47 (1969).
Hodge, R. L., Ng, K. K. F., Vane, J. R.: Disappearance of angiotensin from the circulation of the dog. Nature (Lond.)215, 138–141 (1967).
Jensen, E. V., Jackson, H. I.: Basic guides to tne mechanism of oestrogen action. Recent Progr. Hormone Res.18, 387–414 (1962).
Khairallah, P. A., Page, I. H., Bumpus, F. M., Smeby, R. R.: Angiotensin II: its metabolic fate. Science138, 523–525 (1962).
Lanson, H. D.: Metabolism of antidiuretic hormones. Amer. J. Med.42, 713 to 744 (1967).
Leary, W. P., Ledingham, J. C.: Removal of angiotensin by isolated perfused organs of the rat. Nature (Lond.)222, 959–960 (1969).
Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with Folin Phenol reagent. J. biol. Chem.193, 265–275 (1951).
Methot, A. L., Meyer, P., Biron, P., Lorain, M. F., Lagrue, G., Milliez, P.: Hepatic inactivation of angiotensin. Nature (Lond.)203, 531–532 (1964).
Morgat, J. L., Lam Thanh Hung, Fromageot, P.: Preparation of highly labelled3H-angiotensin II. Biochim. biophys. Acta (Amst.)207, 374–376 (1970).
Osborne, M. J., Angles d'Auriac, G., Meyer, P., Worcel, M.: Mechanism of extraction of angiotensin II in coronary and renal circulations. Life Sci.9, (part I), 859–867 (1970).
Osborn, E. C., Hughes, S. G., Pirie, A. T., Willicombe, P. R., Mahler, R. F.: Clearance studies of angiotensin II and (35S) phenylthiocarbamylangiotensin II in sheep and dog. Cardiovasc. Res.3, 134–146 (1969).
Rosendorff, C., Lowe, R. D., Lavery, H., Cranston, W. I.: Cardiovascular effects of angiotensin mediated by the central nervous system of the rabbit. Cardiovasc. Res.4, 36–43 (1970).
Scroop, G. C., Lowe, R. D.: Central pressor effect of angiotensin mediated by the parasympathetic nervous system. Nature (Lond.)220, 1331–1332 (1968).
Volicier, L., Loew, C.: Penetration of angiotensin into the brain. Fed. Proc.29, abstract no 197 (1970).
Wilzbach, K. E.: Tritium-labeling by exposure of organic compounds to tritium gas. J. Amer. chem. Soc.79, 1013 (1957).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Osborne, M.J., Pooters, N., Angles d'Auriac, G. et al. Metabolism of tritiated angiotensin II in anaesthetized rats. Pflugers Arch. 326, 101–114 (1971). https://doi.org/10.1007/BF00586903
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00586903